Guangdong Taiantang Pharmaceutical Co.,Ltd. Posted 62.5 Million Yuan Net Loss in First Quarter of 2023

Guangdong Taiantang Pharmaceutical Co.,Ltd. (广东太安堂药业股份有限公司) (002433.SZ) reported a net loss of 62.5 million yuan in the first quarter of 2023, widening 51.5% year-on-year.

Meanwhile, the company posted 139.3 million yuan in revenue, down 27.2% year-on-year.

At the end of the reporting period, it had 6.3 billion yuan in total assets and 2.7 billion yuan in total liabilities, with a liability-to-asset ratio of 42.3%.